Satsuma Pharms Drug Patent Portfolio
Satsuma Pharms owns 1 orange book drug protected by 6 US patents Given below is the list of Satsuma Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11744967 | Intranasal delivery devices | 12 Oct, 2041 | Active |
| US12102754 | Intranasal delivery devices | 12 Oct, 2041 | Active |
| US10758532 | Compositions, devices, and methods for treating or preventing headaches | 11 Dec, 2039 | Active |
| US12263162 | Compositions, devices, and methods for treating or preventing headaches | 11 Dec, 2039 | Active |
| US10792253 | Pharmaceutical compositions | 04 Aug, 2037 | Active |
| US11872314 | Pharmaceutical compositions | 04 Aug, 2037 | Active |
Satsuma Pharms's Family Patents
Satsuma Pharms Drug List
Given below is the complete list of Satsuma Pharms's drugs and the patents protecting them.
1. Atzumi
Atzumi is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11744967 | Intranasal delivery devices |
12 Oct, 2041
(16 years from now)
| Active |
| US12102754 | Intranasal delivery devices |
12 Oct, 2041
(16 years from now)
| Active |
| US10758532 | Compositions, devices, and methods for treating or preventing headaches |
11 Dec, 2039
(14 years from now)
| Active |
| US12263162 | Compositions, devices, and methods for treating or preventing headaches |
11 Dec, 2039
(14 years from now)
| Active |
| US10792253 | Pharmaceutical compositions |
04 Aug, 2037
(12 years from now)
| Active |
| US11872314 | Pharmaceutical compositions |
04 Aug, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atzumi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List